Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, and Usono, a developer of innovative ultrasound accessories unveils wireless and wearable ultrasound imaging solution for researchers studying the anatomy of people while they move. Clarius ultrasound tools for research provide access to raw data collected internally, gyroscope collection, a programable interface, and custom software for real-time analysis anywhere.
The wearable ultrasound solution, which pairs a Clarius HD3 high-definition wireless ultrasound scanner with research software and Usono’s ProbeFix Dynamic, enables hands-free, stable, and reproducible ultrasound imaging during exercise and other activities where motion and continuous scanning is crucial. It’s the first wireless dynamic ultrasound imaging solution for researchers in the fields of sports medicine, rehabilitation, and other related areas.
Under the terms of the international agreement, Usono is now a global distributor of Clarius wireless ultrasound scanners combined with research software and its own probe holders. The companies will also engage in co-marketing efforts to promote the combination of their technologies to researchers and clinicians.
New research from New York City reveals that children in low-food-security households are more likely to consume sugar-sweetened beverages (SSBs). Factors such as chronic stress
Kiniksa Pharmaceuticals has been focused on protecting inventions in Australia(AU) with two publications in Q2 2024 The Australia(AU) Patent Office dominates the patent filings with
Clarius & Usono to Bring Wireless, Wearable Ultrasound Imaging to Researchers
by Fred Pennic Leave a Comment
What You Should Know:
How food insecurity fuels sugary drink consumption in vulnerable kids
New research from New York City reveals that children in low-food-security households are more likely to consume sugar-sweetened beverages (SSBs). Factors such as chronic stress
Report: Generative AI and Integration Key to Bridging Payer-Provider Gap
What You Should Know: – A new report by HFS Research, in collaboration with Cognizant, sheds light on critical trends shaping the future of healthcare
Kiniksa Pharmaceuticals sees highest filings and grants during April in Q2 2024
Kiniksa Pharmaceuticals has been focused on protecting inventions in Australia(AU) with two publications in Q2 2024 The Australia(AU) Patent Office dominates the patent filings with